846 results on '"Kobayashi H"'
Search Results
2. Tadalafil treatment might be effective for BPH patients with metabolic syndrome
3. Regular sleep habits with appropriate bedtime prolong hours to undisturbed sleep and reduce nocturnal urine volume per hour
4. Personalized bedtime determined by a wearable device improves nocturia; A prospective interventional crossover study
5. LBA31 Randomized phase III trial of maintenance chemotherapy with tegafur-uracil versus observation following concurrent chemoradiotherapy for locally advanced cervical cancer, GOTIC-002 LUFT trial
6. 446 THE EFFECT OF THE MEDICATIONS BY ALPHA-1 BLOCKERS AND 5 ALPHA REDUCTASE INHIBITORS FOR CHRONIC PROSTATIC INFLAMMATION.
7. 164 ANTICHOLINERGIC BURDEN DECREASES VOIDING EFFICIENCY IN THE ELDERLY FACILITIES.
8. Assembly of flexible nanohelix films: stress–exporting insights into the electrochemical performance of lithium–ion batteries
9. P46.04 Different Effects of Crizotinib Treatment in Three Lung Adenocarcinoma Patients With Various ROS1 Fusion Variants
10. 1651P Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
11. 1249P Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight
12. Retraction notice to “Intelligent cooling water control for a medical accelerator by application of fast feed-forward for future” [Nucl. Instrum. Methods Phys. Res. A 931 (2019) 29–36]
13. P76.68 The Impact of Eligibility for Anti-Angiogenic Treatment to the Prognosis of Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations
14. P19.02 Association between Number of Residual Metastases and Patterns of Progression on EGFR TKI in EGFR mutated Non-Small Cell Lung Cancer
15. P34.07 Quantification of BIM mRNA In Circulating Tumor Cells Of Osimertinib-treated Patients with EGFR Mutation-positive Lung Cancer
16. 236O Olaparib (ola) plus bevacizumab (bev) as maintenance (mx) therapy in patients (pts) with newly diagnosed advanced ovarian carcinoma (OC): Japan subset of the PAOLA-1 trial
17. 812MO Maintenance olaparib + bevacizumab (bev) in patients (pts) with newly diagnosed advanced high-grade ovarian cancer (HGOC): RECIST and/or CA-125 objective response rate (ORR) in the phase III PAOLA-1 trial
18. Aerosol spread with use of high-flow nasal cannulae: a computational fluid dynamics analysis
19. Usefulness of robot-assisted laparoscopic partial nephrectomy using trifecta criteria
20. Regularized, parameter free scale similarity type models for Large Eddy Simulation
21. Sensitivity improvement of bio-molecules using ionic liquid matrix in mega electron volt secondary ion mass spectrometry
22. Nosocomial infection by human bocavirus and human rhinovirus among paediatric patients with respiratory risks
23. Percutaneous nephrostomy-assisted ureterorenoscopy (PAU) for an impacted ureteral stone: A clinical study of super-minimally invasive endourology
24. Spread of tumour and adverse events after modified radical hysterectomy for FIGO Stage IB1 cervical cancer patients with tumour diameter preoperatively estimated 2 cm or less: Japan Clinical Oncology Group trial (JCOG1101); exploratory analysis before primary analysis
25. An autopsy case of elderly-onset influenza-associated encephalopathy (IAE)
26. OA02.06 The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L)
27. Single-Institution Experience in 3D MRI/CT-Based Brachytherapy for Cervical Cancer
28. Analytical calculation method of effect of interconnect layer damage on power cycling lifetime
29. Predictive value of PI-RADS score for pT3 prostate cancer in robot-assisted radical prostatectomy
30. Quantitative measurement of temperature in oxygen enriched CH 4 /O 2 /N 2 premixed flames using Laser Induced Thermal Grating Spectroscopy (LITGS) up to 1.0MPa
31. Quantitative measurement of temperature in oxygen enriched CH 4 /O 2 /N 2 premixed flames using Laser Induced Thermal Grating Spectroscopy (LITGS) up to 1.0MPa
32. RETRACTED: Intelligent cooling water control for a medical accelerator by application of fast feed-forward for future
33. Our ideas and devices to establish stable and precise procedures in robotic radical trachelectomy for cervical cancer patients
34. EP-1401 Practice-based clinical outcome of definitive radiation therapy for superficial esophageal cancer
35. Novel auto-startup technology for two cavities of a medical accelerator with one RF source
36. 04:12 PM Abstract No. 429 Experimental study on the expansion rate and the density of a cast made from N-butyl cyanoacrylate in vitro
37. Substitution effect of V, Ca, and Ba on the thermochromic properties and thermal expansion of SrZr4(PO4)6
38. States change of carbon at the boundary to TiO2 toward better electrical conductivity via a combined mechanochemical - Thermal route
39. A Retrospective Study of 3D-CRT/IMRT and Concomitant Intra-arterial Chemotherapy for Maxillary Sinus Carcinoma
40. Preliminary Results of Intracavitary/Interstitial MRI/CT-Based Cervix Brachytherapy using Non Intracavitary/Interstitial (IC/IS) Dedicated Applicator
41. MA23.11 Lobe-Specific Nodal Dissection for Clinical Stage I and II Non-Small Cell Lung Cancer: Japanese Multi-Institutional Retrospective Study
42. P3.01-54 A Historical Comparison of Patients with Advanced NSCLC Harboring Uncommon EGFR Mutations Before and After the Approval of Afatinib in Japan
43. Survival effect of lncRNA-X expression in EGFR-mutant adenocarcinoma
44. Soft coagulation in robot-assisted partial nephrectomy: Minimally invasive sutureless technique
45. Non-destructive estimation method on cosmic ray ruggedness of power semiconductors using repetitive monitoring technique
46. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project
47. Osteoarthritis-associated catabolic factor, interleukin-1B downregulates chondrocyte energy metabolism through the modulation of adenosine monophosphate-activated protein kinase and sirtuin 1 in OA
48. L’édoxaban diminue l’incidence des événements thrombo-emboliques asymptomatiques sur les phlébographies après ostéotomie tibiale de fermeture
49. Edoxaban is effective in reducing the incidence of asymptomatic phlebographic events following closed-wedge high tibial osteotomy
50. P2.02-057 Expression of MGAT4a and MGAT5 Are Correlated with Poorer Outcome in Advanced Lung Adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.